Tuesday, 02 January 2024 12:17 GMT

WELL Health Technologies Corp.


(MENAFN- Baystreet) 09:51 AM EST - WELL Health Technologies Corp.: Announced its interim consolidated financial results for the quarter ended September 30, 2025. WELL achieved record quarterly revenues of $364.6 million in Q3-2025, an increase of 56% compared to Q3-2024 driven by organic growth and acquisitions. WELL achieved record Adjusted EBITDA of $59.9 million in Q3-2025, an increase of 296% compared to $15.1 million in Q3-2024, representing Adjusted EBITDA margin of 16.4%. WELL Health Technologies Corp. shares T are trading up $0.03 at $4.93.

MENAFN06112025000212011056ID1110306065



Baystreet.ca

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search